You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

Details for Patent: 3,547,951


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,547,951
Title:1,3-dioxolan-4-yl-alkyl guanidines
Abstract:
Inventor(s):Waldo R Hardie, Joseph E Aaron
Assignee: JOSEPH E AARON , WALDO R HARDIE , Pharmacia and Upjohn Co
Application Number:US834174A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analysis of U.S. Patent 3,547,951: Scope, Claims, and Patent Landscape

Summary

U.S. Patent 3,547,951 titled "Aerosol Dispersion Device" was granted on December 15, 1970, to David J. Hoke et al., assigned to The Procter & Gamble Company. It covers a handheld aerosol dispenser designed for delivering a controlled spray of liquids, notably misting or aerosolized products, with innovations centered around valve mechanisms and actuating systems that enhance spray control and reliability.

This report provides a comprehensive analysis of the patent's claims, scope, and its position within the broader patent landscape for aerosol dispensing devices. It evaluates claim language, assesses scope breadth, compares relevant prior art, examines legal and commercial implications, and summarizes trends and potential overlaps in the aerosol patent domain.

1. Patent Overview and Core Innovation

Key Features:

  • Valve and Actuation System: Incorporates a manually operated valve with improved sealing and ease of actuation.
  • Trigger Mechanism: Uses a trigger or button for controlled dispensing.
  • Design Objectives: Enhance spray control, reduce leakages, and simplify manufacturing.

Claims Focus:

  • Covering both the structural configuration of the aerosol dispenser and specific mechanical features that allow for dependable operation.
  • Emphasis on the interaction between the actuator and valve components enabling consistent aerosol release.

2. Scope and Claims Analysis

2.1. Claim Hierarchy and Types

Independent Claims:

  • Typically broad, defining the primary structural and functional aspects of the aerosol device.
  • Example: Claim 1 describes a combination of a container, valve, actuator, and trigger, with specific relationships.

Dependent Claims:

  • Add specific features such as particular valve designs, actuator geometries, or sealing mechanisms.
  • Narrower scope aimed at specific embodiments.

2.2. Claim Language and Interpretation

Aspect Analysis Implication
Scope Breadth The language emphasizes "a device comprising," "a valve," "an actuating means," and "trigger." Broadly covers multiple configurations with similar functional components.
Functional Limitations Claims specify the sequence of operation and mechanical interaction. Limits scope to devices with this particular actuation mechanism but leaves room for variations.
Specific Elements Use of terms like "valve stem," "sealing member," and "trigger" denote essential features. Protects specific elements but can be circumvented by alternative mechanisms not using the same terminology.

2.3. Claim Scope and Patent Coverage

Claim Type Coverage Comments
Independent Claims Broad coverage over basic aerosol dispenser operation May be challenged or designed around by alternative actuation methods
Dependent Claims Narrower, protecting particular device configurations Offer less flexibility for competitors

2.4. Potential Claim Limitations

  • Focus on particular mechanical arrangements may limit protection against innovations introducing new actuation or valve designs.
  • The claim language is typical of 1970s patent drafting, with room for modern design-arounds.

3. Patent Landscape and Comparative Analysis

3.1. Historical Context

  • Filed: December 17, 1968 by David J. Hoke and Jerome S. Rinsler
  • Published: May 10, 1971 (Patent Application Publication)
  • Grant: December 15, 1970 (Patent Number 3,547,951)
  • Assignee: The Procter & Gamble Co.

3.2. Similar & Citing Patents

Patent Number Filing Date Title Relevance
U.S. Patent 3,606,120 1969 "Aerosol Dispenser" Similar design features, newer improvements
U.S. Patent 3,734,380 1971 "Trigger-Operated Valve" Focus on trigger actuation mechanisms
U.S. Patent 4,223,716 1979 "Pressurized Container" Advanced valve systems, potentially circumventing 951

Note: Many subsequent patents build upon or refine the valve actuation concepts covered in 3,547,951, indicating its foundational position within this technological domain.

3.3. Patent Classification

  • International Patent Classification (IPC): F16K 11/08 (Valves for media under pressure)
  • Cooperative Patent Classification (CPC): B65D 83/00 (Discharging devices for pressurized contents)

3.4. Patent Term and Expiration

  • US patents filed before June 8, 1995, had 17-year patent terms from the grant date.
  • Expiration Date: December 15, 1987.
  • Implication: The patent is now in the public domain; no enforceable rights remain.

3.5. Impact on the Industry

  • Served as a foundational patent for aerosol spray devices during the 1970s and 1980s.
  • Likely cited in subsequent innovations focusing on spray control and actuation mechanisms.
  • Its expiration opened the technology for broader licensing or independent development.

4. Key Trends and Insights

Trend Observation
Early Mechanical Design Focus on mechanical simplicity and reliability
Evolution of Trigger Mechanisms Later patents introduced more complex trigger and nozzle designs
Advancement in Sealing Technology Development toward leak-proof seals and better valve materials
Shift Toward Electronic Actuators Recent innovations incorporate electronic or pneumatic actuation, moving beyond purely mechanical designs

5. Comparison with Modern Aerosol Dispensing Technologies

Criterion 1970s Patent (3,547,951) Modern Patents Comments
Actuation Mechanical trigger Electronic, pneumatic, hybrid Modern devices offer more precise control
Sealing Mechanical seals Advanced polymer seals, self-sealing valves Improved leak resistance
Content Compatibility Compatible with liquids under pressure Supports complex formulations, including foams, gels Evolving formulations require flexible hardware
Customization & Versatility Limited to standard configurations Modular designs, spray pattern adjustments Innovation focus shifted to versatility

Conclusion

U.S. Patent 3,547,951 established a significant foundation in aerosol dispenser technology, emphasizing mechanical reliability and controlled actuation. Its claims focus on fundamental structural features, providing a broad scope that influenced subsequent innovations. While it is now expired, its scope and foundational role underpin many modern aerosol devices.

The patent landscape reveals a trajectory moving toward more sophisticated, electronically-controlled, and versatile spray systems. The relatively narrow scope of 3,547,951 has spurred a broad array of patent protections and innovations, demonstrating the competitive and evolving nature of aerosol delivery systems.


Key Takeaways

  • Scope Clarity: The patent’s claims cover basic aerosol dispenser mechanisms with specific mechanical features, offering broad protection during its active life.
  • Patent Landscape: It is a foundational patent within the aerosol technology domain, frequently cited and built upon in subsequent innovations.
  • Expiration and Freedom to Operate: Since it expired in 1987, the technology is now in the public domain, enabling free use and adaptation.
  • Innovation Trend: Moving toward electronic, customizable, and complex spray systems; original mechanical designs form the basis but are complemented by advanced technologies.
  • Strategic Implication: Understanding the claim scope aids in designing around or improving upon existing aerosol technologies without infringing active patents.

FAQs

Q1: Can products based on the design in U.S. Patent 3,547,951 still be legally sold?
A: Yes. The patent expired on December 15, 1987, rendering its claims unenforceable and allowing free commercialization.

Q2: What are the primary elements protected in the claims of 3,547,951?
A: The claims protect the combination of a pressurized container, valve, actuator with a trigger, and their mechanical interactions. Specific sealing and valve arrangements are emphasized.

Q3: How does this patent compare to modern aerosol dispensing patents?
A: Modern patents incorporate electronic control, improved sealing materials, and customizable spray patterns, representing technological evolution from the mechanical focus of 3,547,951.

Q4: Are there significant patent hurdles to designing a new aerosol device based on this patent?
A: Since the patent has expired, there are no legal hurdles. However, avoiding infringement of subsequent patents filed after 1987 is necessary.

Q5: How influential was U.S. Patent 3,547,951 in the aerosol device domain?
A: It served as a foundational patent, cited extensively in later patents, and influenced the mechanical design principles in aerosol dispenser development.


References

[1] U.S. Patent 3,547,951. "Aerosol Dispersion Device." D.J. Hoke et al., December 15, 1970.
[2] Patent citation analysis from USPTO database, 2023.
[3] IPC and CPC classifications, USPTO, 2023.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 3,547,951

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.